Neurofibromatosis 2 (NF2) is a rare genetic disorder that causes noncancerous tumors on nerves in the brain and spinal cord. These tumors can affect hearing, vision, and balance. About half of the ...

Meningioma has been recognized as the most common primary intracranial tumor and accounts for 30% of all central nervous system tumors, with an annual incidence of 5/100,000 1,2,3. According to the ...

The alternative text for this image may have been generated using AI. This review will discuss the contribution of merlin loss of function in NF2-related tumors and common human cancers and the ...

Neurofibromatosis type 2 is caused by a change in the NF2 gene located on chromosome 22. This gene encodes a protein known as merlin. Mutations in the NF2 gene disrupt the function of merlin, which is ...

The type 2 neurofibromatosis (NF2) treatment candidate 'Trineumin', currently under development by PRG S&Tech, has received ...

Neurofibromatosis type 2 is most often diagnosed based on the presence of physical symptoms that are part of the specific diagnostic criteria for the disorder. Genetic testing for the NF2 mutation is ...

Patients with a genetic syndrome called NF2-related schwannomatosis (NF2-SWN) have tumors that develop on the covering of the brain or grow along the nerves in the brain, spinal cord, and/or other ...

The proteins that provide cells with a sense of personal space could lead to a therapeutic target for Neurofibromatosis Type 2 (NF2), an inherited cancer disorder, according to researchers at The ...